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In 2003, 25 years after Rosalynn Carter chaired the first
Presidential Commission on Mental Health, she testified
before the New Freedom Commission on Mental Health,
chaired by Michael Hogan.
1 When asked what the great-
est advance had been in the intervening years, she said it
was adopting the belief that people with serious mental
illness could recover.
As heterogeneous as people with schizophrenia are, so
too are their paths to recovery. Recovery may proceed
along multiple domains: psychotic symptoms, cognitive
capacities, functioning in terms of independent living
in the community, competitive employment, social and
intimate relationships (‘‘a home, a job and a date on
the weekend’’), physical health, economic health, and
other aspects of quality of life.
2 To the extent we recog-
nize andrespondtothe diversedomainsofa person’slife,
we will help people in the work of crafting a life.
We comment on this series of reports describing the
challenges of measuring recovery from schizophrenia
and identifying predictors of recovery. We offer these
comments as public mental health system administrators
charged with promoting recovery, including knowing
whether the services being purchased with public funds
are promoting recovery. Such knowledge requires
measurement. Is the intervention being carried out
with fidelity? As both administrators and as evalua-
tors/researchers, we look to our colleagues in the field
to offer measurement tools of immediate practical signif-
icance to consumers and clinicians.
Freseetal
3depictanevolvingconceptofrecoveryfrom
schizophrenia. They note that the medical model of the
1950s had to be expanded to include social aspects of the
disorder because of the supports needed by people with
serious mental illnesses whose residences were shifted
during the era of deinstitutionalization from the hospital
to the community. Medical care alone was not adequate
to allow community living, and soon it became apparent
that the ‘‘psychosocial’’ aspects of these disorders could
not be divorced from medical considerations, thereby
prompting more holistic views of recovery from schizo-
phrenia.
Freseandcolleagues
3goontonotethatwiththereport
of the President’s New Freedom Commission in 2003,
a clinical emphasis on recovery became not only possible
but also expected. As administrators and public policy
decision makers, we must ask ourselves how to engender
this optimism in staff who may view success as showing
up for a day treatment program 5 days per week. These
authors also call our attention to the damage that can be
wrought by isolating our vision to the psychosocial
aspects of recovery and ignoring the nature of the illness
from which the person is recovering: it would be just as
short-sighted to ignore the illness as it has been to ignore
the person with the illness. They illustrate this point by
listing the Substance Abuse and Mental Health Services
Administration’s recovery principles, which read so ge-
nerically that one could address them all without attend-
ing to a person’s need for medical treatment. Adopting
a view of recovery that marginalizes the fact that there
is an illness to recover from can perversely serve a payer’s
fiscal interests. We see this, eg, when a managed care or-
ganization hires peer counselors (often with great fan-
fare) while leaving large numbers of clinical positions
unfilled. The article by Frese et al
3 reminds us not to
let assertions of being a recovery-focused system be a cover
for shoddy attention to distressing disease symptoms.
Frese and colleagues
3 also provide brief bios of them-
selves and some of the other consumer leaders of the re-
covery movement who are mental health professionals.
They use these personal descriptions to illustrate the di-
vergenceofopiniononrecovery,particularlywithrespect
to the importance of the biological aspects of schizophre-
nia. These opinions speak to the diversity of values we all
face when trying to achieve balance in policy and practice
for mental health systems of care. Several of the other
articles in the series grapple with the need for language
and measures that could provide the diversity to assess
programs for their effectiveness toward recovery.
Harvey and Bellack
4 propose a language for discussing
recovery. They start with what most understand about
functional recovery and then examine how its component
parts might be measured, noting the value judgments this
entails. They also remark, in essence, that it is easier to
look for your keys under a lamppost than in darker,
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mance measures have detailed norms but, at least as
yet, are of little use in measuring recovery from schizo-
phrenia. In contrast, no such norms exist for those meas-
ures consumers (and public policy leaders) value, namely
residential independence, employment, and a social life.
While measures of cognitive functioning may have high
reliability,theylackvalidityandmeaningfulnesswithrespect
tomeasuringfunctionalimpairmentinreal-worldactivities,
thedomainsmostimportanttoconsumersandtheirfamilies.
Harvey and Bellack
4 introduce a notion of ‘‘breadth of
success’’ perhaps to counter a narrow emphasis on symp-
toms. They assertthat doing ‘‘prettygood’’ ina varietyof
important life domains constitutes being recovered,
which has great face validity because lives are lived in
many areas. They also broaden considerations to include
effort and societal barriers as significant influences on
paths to recovery. As treatment professionals, we cannot
just say ‘‘good enough’’ when someone’s symptoms are
gone or minimally intrusive, yet the person has no job
or home or friends. The schema proposed by Harvey
and Bellack
4 allows functional remission (being pretty
good across multiple domains) to be measurable at the
same time as clinical remission.
Mausbach et al
5 review various instruments for mea-
suring functional recovery among people with psychotic
disorders. There is no gold standard. As believers in mea-
surement-based interventions, we regard such instru-
ments as vital. Measurement should let consumer and
clinician know whether an intervention is having the de-
sired impact so as not to waste the consumer’s time or the
system’s resources. To be useful in routine practice set-
tings, such measures must be able to be incorporated
readily into treatment activities. These authors propose
a 30-minute cutoff as the threshold for giving a scale
an ‘‘A’’ rating for ease of administration. The disconnect
here is that what is brisk to the researcher (a 30-minute
assessment of functioning) will simply not fly in mental
healthsystemsasweknowthem.Thatsaid,weappreciate
their widening the light under the lamppost by creating
measures that reflect real-world functioning. This is an
important work in progress.
ThestudyofWunderinketal
6ofpredictorsofrecovery
for people with a first psychotic episode tells a story with
a 1-2 punch: treatment works and early treatment works
muchbetter.ThisDutchstudyshowedthatrecoveryafter
2 years was significantly associated with a short duration
(mean 32 d) of untreated psychosis. The nonrecovered
patients, in contrast, went approximately 10 times as
longbeforeenteringtreatment(321d).Enteringtreatment
within32daysoftheonsetofapsychoticillnessisstagger-
ingly prompt by US standards. While the study design
couldnotassigncausality,thefindingssuggesttheimpor-
tance of early entry to treatment in promoting functional
recovery. Clearly, this is an area where more research is
needed to inform practice, and the National Institute of
MentalHealthisheaded in thisdirectionwith its Recovery
After Initial Schizophrenia Episode initiative.
Mohamed et al
7 use correlational data, some available
from randomized trials conducted to address other pri-
mary outcomes, to make the case for helping people
with schizophrenia gain insight into their illness and or
the utility of medication in decreasing schizophrenia
symptoms. Their finding that declining schizophrenia
symptoms were accompanied by increasing levels of de-
pression may also support the nonlinear and disparate
aspects of recovery. The authors point out that the in-
crease in depression as psychotic symptoms improve
may reflect the emergence of individuals’ recognition
of the discrepancy between current and desired function-
ing. They note, optimistically, that this realization could
motivate individuals to move on with their recovery.
Leaders in clinical administration and policy have the
challenge of helping frontline staff gain the clinical skills
to recognize how to use such feelings to help promote a
depressed individual’s motivation for positive change.
Policy makers and program directors ask, ‘‘What treat-
mentspromotefunctionalrecoveryforpeoplewithschizo-
phrenia?’’ The report by Kern et al
8 makes a compelling
casefortheinteractionbetweenpharmacologicalandpsy-
chosocial treatments and concludes that the whole is
greaterthanthesumofitsparts.Theauthorsstresstheim-
portanceofrememberingboththepersonandtheillnessas
opposed to settling for symptom stabilization. Two of the
psychosocial treatments considered (social skills training
andcognitivebehavioraltherapy)havestrongevidenceba-
ses tosupportthem.Theother 2 interventionsconsidered,
cognitiveremediationandsocialcognition,haveanemerg-
ingevidencebasethatdoesnotyetmeetthelevelofsupport
neededfrommultiplerandomizedtrialsbyseparategroups
of investigators.
The report by McGurk et al
9 makes a strong case that
vocational rehabilitation plus cognitive remediation is
more effective than cognitive remediation alone in im-
proving work outcomes. The administrator with finite
resources is left wondering whether the cognitive
remediation platform itself adds value or whether a ‘‘vo-
cational rehabilitation’’–alone arm would have achieved
the same results. The extent to which improvements in
cognitive tasks result in improvements in functioning is
an open and important question because cash-strapped
public mental health systems consider where to invest
resources for the greatest impact. Should these interven-
tions be reimbursable services? If so, for whom, when,
and under what conditions?
Kern et al
8 are careful to say that it may not be reason-
able to ask cognitive training approaches, if used in iso-
lation, to show an impact on functioning. Rather, it may
be that some form of ‘‘talking therapy’’ may be necessary
to facilitate the translation of gains from training exer-
cises to real-world problems. The pharmacology studies
summarized by these authors also make the case that
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improve functioning. They make the case like others
that a recovery-oriented treatment should draw from
broad yet individualized approaches—each with speci-
fied goals and objectives.
This ensemble of articles usefully characterizes efforts
underwaytomoveanecdotetosciencebyimprovingmeth-
ods for measuring recovery for people with schizophrenia
and other serious mental illnesses. Indeed, as Mrs Carter
suggested, we have entered the age of recovery and are
now searching for good evidence of what works. To do
so, we need clear definitions of the domains of recovery
that are meaningful to consumers, families, and clinicians
and reliable, feasible, and valid measures of response to
interventions, whether these be biological, psychological,
or social in nature. It is heartening to see this work under-
way because it can only deepen our understanding and
commitment to building recovery-oriented services.
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